Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Secondary mitochondrial diseases]

F Cardellach1, J Casademont, A Urbano-Márquez

  • 1Servicio de Medicina Interna General, Hospital Clinic, Universidad de Barcelona, España. cardell@medicina.ub.es

Revista De Neurologia
|November 12, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicted change in the number of permanent medical teachers from 2017 to 2026. The training of future physicians in critical condition.

Revista clinica espanola·2018
Same author

Cardiac and placental mitochondrial characterization in a rabbit model of intrauterine growth restriction.

Biochimica et biophysica acta. General subjects·2018
Same author

RECALMIN II: Information for improving the country's Internal Medicine Services.

Revista clinica espanola·2017
Same author

Healthcare systems and alcohol consumption - can they coexist?

Revista clinica espanola·2017
Same author

Influence of Mitochondrial Genetics on the Mitochondrial Toxicity of Linezolid in Blood Cells and Skin Nerve Fibers.

Antimicrobial agents and chemotherapy·2017
Same author

Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder.

Parkinson's disease·2017
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles

Secondary mitochondriopathies involve mitochondrial dysfunction from external causes. Understanding these conditions aids in identifying triggers and developing targeted treatments for better patient outcomes.

Area of Science:

  • Mitochondrial biology
  • Cellular pathology
  • Biochemistry

Context:

  • Secondary mitochondriopathies arise from extragenic factors affecting mitochondrial structure and function.
  • These conditions encompass a range of etiologies including metabolic deficiencies, endocrine disorders, ischemia-reperfusion injury, sepsis, toxins, drugs, and aging.
  • Mitochondrial dysfunction is implicated in oncogenesis and apoptosis, highlighting its role in complex diseases.

Purpose:

  • To categorize and analyze secondary mitochondriopathies based on their underlying causes.
  • To provide a framework for understanding diverse conditions that lead to mitochondrial dysfunction.
  • To explore the relationship between mitochondrial abnormalities and disease processes.

Summary:

  • Secondary mitochondriopathies are classified into nine groups based on external causative factors.

Related Experiment Videos

  • These include specific metabolite deficiencies, endocrinopathies, ischemia-reperfusion, sepsis, toxins, drugs, aging, oncogenesis, and apoptosis.
  • Mitochondrial respiratory chain deficiency is also considered within this classification.

    • Impact:

    • Improved understanding of secondary mitochondriopathies can lead to the identification and elimination of causative agents.
    • This knowledge facilitates the development of targeted therapeutic strategies for mitochondrial disorders.
    • Effective management of secondary mitochondriopathies can potentially reverse mitochondrial dysfunction and improve patient prognosis.